InvestorsHub Logo
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: None

Friday, 10/20/2017 4:27:01 PM

Friday, October 20, 2017 4:27:01 PM

Post# of 7747
Guys, the recent sec filing is clear. NASDAQ panel will grant continual list only if RS pass or somehow SP goes above 1$ for 10 days before Nov 15. That's very little time from now. So I won't count on SP to go above 1$, it would have to happen by Nov 5th two weeks from now.

So RS result being pushed back to 10/27 determines whether or not company stay on NASDAQ. SK is basically telling you, if you vote no, we all go to OTC.

If vote is still no, we potentially go even lower if we hit OTC. If vote is yes, RS will happen almost immediately. So short term prediction is bearish, but I am not saying long term it will not rise.

There are too much uncertainty such as will SK raise more capital after RS? How soon can NantCell file the NDA and set a PDUFA date for expected FDA approval on STS.

New combo study isn't really news that would add value right away. I'm still watching closely.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.